Showing results (51-60 of 463) with videos related to
Sort By:
Pageof 47
American Heart Journal|August 17, 2004
Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialDeepak L Bhatt, Eric J Topol, Controlled Clinical Trials|September 23, 2003
A matter of life and death? The Heart Protection Study and protection of clinical trial participantsRaymond Q Migrino, Eric J Topol, Current Pharmaceutical Design|February 18, 2004
Adjunctive therapy for percutaneous revascularization in acute myocardial infarctionSorin J Brener, Eric J TopolCurrent Problems in Cardiology|June 24, 2005
Molecular mechanisms of myocardial infarctionBrian K Jefferson, Eric J TopolNature Biotechnology|November 10, 2012
Pharmacogenomics in clinical practice and drug developmentAndrew R Harper, Eric J TopolNature Medicine|July 9, 2026
Biological aging clocks in health and diseaseTony Wyss-Coray, Eric J TopolAnnals of Internal Medicine|January 22, 2021
The Proportion of SARS-CoV-2 Infections That Are Asymptomatic : A Systematic ReviewDaniel P Oran, Eric J TopolReviews in Cardiovascular Medicine|August 11, 2004
Pathobiology of atherosclerosis: are there racial and ethnic differences?Karol E Watson, Eric J TopolNature Reviews. Drug Discovery|January 2, 2003
Scientific and therapeutic advances in antiplatelet therapyDeepak L Bhatt, Eric J TopolPageof 47